ROACTEMRA

Solution for injection in pre-filled syringe, 162mg
RxActive license

Active substance (INN)

tocilizumab

Pharmaceutical form

Pharmaceutical formSolution for injection in pre-filled syringe
Strength162mg
PackagingUkupno 4 napunjena injekciona šprica sa iglom sa po 0.9ml rastvora za injekciju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L04AC07)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateOctober 6, 2025

Analogs in Montenegro

3

Other medicines with the same active substance

ROACTEMRA®Rx
Concentrate for solution for infusion, 80mg/4mlF.Hoffmann-La Roche Ltd.
ROACTEMRA®Rx
Concentrate for solution for infusion, 200mg/10mlF.Hoffmann-La Roche Ltd.
ROACTEMRA®Rx
Concentrate for solution for infusion, 400mg/20mlF.Hoffmann-La Roche Ltd.
Source: CInMED register